Image

FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor Disease

FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor Disease

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The purpose of this study is to find out whether a dietary approach that includes prolonged overnight fasting, guided by a Mediterranean-style eating pattern, is feasible for patients with myeloma precursor disease or newly diagnosed multiple myeloma.

Eligibility

Inclusion Criteria:

  1. 18 years of age or older.
  2. Any sex/gender.
  3. Able to provide consent.
  4. Able to speak, read, and understand English or Spanish.
  5. Diagnosis of Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM), or Multiple Myeloma (MM) per standard criteria:
    1. Cohort 1 - Participants must have a confirmed diagnosis of MGUS and SMM.
    2. Cohort 2 - Participants must have a confirmed new diagnosis of MM and be initiating anti-myeloma therapy.
  6. Delivery of anti-myeloma therapies at one of the following institutions:
    1. Sylvester Comprehensive Cancer Center (SCCC) (including satellite/network sites).
    2. University of Miami Health System.
  7. Approval from treating oncologist, confirmed via email or in writing.
  8. Eastern Cooperative Oncology Group (ECOG) Performance Status grade of \<2
    1. PI approval needed if ECOG ≥ 2.
  9. Having not consistently (not equal to or more than 50% of the time) engaged in structured fasting (i.e., not regularly fasting for ≥12hr/night) for the past 3 months.
  10. Not consuming a Mediterranean diet by not meeting 2 or more out of the following 3 Mediterranean eating pattern goals in the prior 3 months: ≥3 servings of vegetables per day, ≥ 3 servings of beans and legumes per week, or ≥ 1 serving of nuts per day.

Mediterranean diet will be screened with select components of a Mediterranean Diet Adherence Screener (MEDAS). 11. Internet access on a smart phone, tablet, or computer. 12. Willing to be randomized to a prolonged overnight fasting and guided Mediterranean dietary intervention or waitlist-control group.

Exclusion Criteria:

  1. Individuals younger than 18 years of age.
  2. Unable to provide consent.
  3. Unable to read or understand English or Spanish.
  4. Any contraindication for diet changes as determined by physician.
  5. History of a clinical eating disorder.
  6. History of dementia or major psychiatric disease.
  7. History of recent (≤1 yr) stroke, myocardial infarction or congestive heart failure.
  8. History of autoimmune disease and on treatment at time of screening.

Study details
    Multiple Myeloma
    Monoclonal Gammopathy of Undetermined Significance
    Smoldering Multiple Myeloma

NCT07446777

University of Miami

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.